title: [Expression of human anti-HBsAg-interferon fusion protein in CHO cells].
abstract: OBJECTIVE
  To study the possibility of expressing human anti-HBsAg-interferon fusion protein in CHO cells as a putative targeting drug for hepatitis B.
  
  
  METHODS
  Both the heavy and light chain genes of human anti-HBsAg antibody derived from a phage display library were fused with alpha-2b interferon (IFN-alpha-2b) gene in vitro by polymerase chain reaction. The IFN alpha-2b gene was placed at the C terminal and a 15 amino acid linker was introduced at the fusion site. The light chain-IFN expression plasmid pLIC was constructed with a mammalian expression vector pcDNA3.1(+) and the heavy chain-IFN expression plasmid pFID was constructed with another mammalian expression vector pCdhfr1. These plasmids and the anti-HBsAg full-length light and heavy chain expression plasmids (pLIC and pHFD, respectively) were transfected into CHO (dhfr-) cells by the following three combinations:I, pLIC + pHFD;II, pLIC + pFID; III, pLFC + pFID. The cultured supernatant of the transfected cells was collected and assayed for IFN activity and HBsAg affinity.
  
  
  RESULTS
  The supernatant of combination I and II displayed IFN activity but only combination I supernatant exhibited HBsAg affinity.
  
  
  CONCLUSIONS
  The successful expression of a fusion protein with both HBsAg affinity and interferon activity may lead to a new way to make a targeting drug for hepatitis B.
authors.affiliation: Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Tong
authors.forename: H
authors.initials: H
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: Xu
authors.forename: L
authors.initials: L
authors.lastname: Fu
authors.forename: C
authors.initials: C
authors.lastname: Yu
authors.forename: G
authors.initials: G
authors.lastname: Liu
mesh_terms: D000818:Animals; D016466:CHO Cells; D006224:Cricetinae; D004797:Enzyme-Linked Immunosorbent Assay; D006509:Hepatitis B / Q000628:therapy; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006801:Humans; D007372:Interferons / Q000096:biosynthesis*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis*
chemical_list: D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D011993:Recombinant Fusion Proteins; D007372:Interferons